Shuttle Pharmaceuticals Inc (NASDAQ: SHPH) — Healthcare · Share Price, Chart & Market Data
About: Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Latest price: $1.03 (+9.77%)
SHPHShuttle Pharmaceuticals Inc
Loading watchlist status…
Trade SHPH now
Shuttle Pharmaceuticals Inc share price
SHPH price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 7:28 am GMT+0
SHPH price performance
4.072%
5D
9.785%
1M
-43.094%
YTD
-86.109%
1Y
SHPH price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 7:28 am GMT+0
SHPH details
SHPH Market Signals